WPRIM Management System> DCMS> Journal of Rheumatic Diseases> 2017> 24

Volume: 24

1. Add-on Clarithromycin and Tacrolimus Treatment for Rheumatoid Arthritis. Page:123—124
2. Aseptic Meningitis and Acute Kidney Injury after Immunoglobulin Infusion in a Patient with Systemic Lupus Erythematosus and Immune Thrombocytopenic Purpura. Page:119—122
3. Pulmonary Arterial Hypertension is Normalized Following Six Years of Inhaled Iloprost Treatment in a Patient with Systemic Sclerosis. Page:114—118
4. Rivaroxaban for Thromboprophylaxis in Patients with Antiphospholipid Syndrome. Page:108—113
5. Meta-analysis of Circulating Adiponectin, Visfatin, and Ghrelin Levels in Patients with Systemic Lupus Erythematosus. Page:99—107
6. Does Painful Heels in Ankylosing Spondylitis Demonstrate Distinctive Features on Plain Radiographs: A Study of 104 Cases. Page:93—98
7. Urinary Tumor Necrosis Factor-like Weak Inducer of Apoptosis as a Biomarker for Lupus Nephritis: A Meta-analysis. Page:85—92
8. Multifocal Osteonecrosis in a Patient with Gout: Case Report and Review of the Literature. Page:246—250
9. A Case of Polymyositis Associated with Immunoglobulin A Nephropathy. Page:241—245
10. Cytoplasmic Anti-Neutrophil Cytoplasmic Antibody Positive Diffuse Alveolar Hemorrhage Associated with Methimazole. Page:236—240
11. Comparing Effectiveness Rituximab (Mabthera®) to Other Second-line Biologics for Rheumatoid Arthritis Treatment in Patients Refractory to or Intolerant of First-line Anti-tumor Necrosis Factor Agent: An Observational Study. Page:227—235
12. Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Undergoing Biologic Disease-Modifying Therapy. Page:220—226
13. Comparative Efficacy and Safety of Secukinumab and Adalimumab in Patients with Active Ankylosing Spondylitis: A Bayesian Network Meta-analysis of Randomized Controlled Trials. Page:211—219
14. Prevalence and Risk Factors Associated with Neutropenia in Hospitalized Patients with Systemic Lupus Erythematosus. Page:203—210
15. Metabolomics Approach to Explore the Effects of Rebamipide on Inflammatory Arthritis Using Ultra Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry. Page:192—202
16. Augmentation Index in Connective Tissue Diseases. Page:185—191
17. Renal Involvement in Rheumatic Diseases. Page:174—184
18. Autologous Haematopoietic Stem Cell Transplantation for Refractory Rheumatic Diseases. Page:171—173
19. A Case of Refractory Oral Aphthous Ulcer Successfully Treated with Adalimumab. Page:157—160
20. Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation for Refractory Rheumatic Diseases. Page:149—156
21. Platelet Distribution Width and Mean Platelet Volume Are Not Correlated with the Disease Activity Indices of Ankylosing Spondylitis. Page:143—148
22. Neutrophil-to-lymphocyte Ratio in Diagnosis of Systemic Sclerosis for Prediction of Interstitial Lung Disease. Page:138—142
23. Differential Diagnosis of Juvenile Idiopathic Arthritis. Page:131—137
24. Hyper-homocysteinemia Inducing Hyperuricemia: What are the Mechanisms?. Page:127—130
25. Is Urinary Tumor Necrosis Factor-like Weak Inducer of Apoptosis a Biomarker of Lupus Nephritis?. Page:125—126
26. Radiotherapy, a New Treatment Option for Non-malignant Disorders: Radiobiological Mechanisms, Clinical Applications, and Radiation Risk. Page:74—84
27. The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus. Page:65—73
28. Risk Factors of Osteoporosis in Rheumatoid Arthritis Patients; Glucocorticoid, Inactivity, or Nutrient Deficiencies. Page:63—64
29. Radiotherapy, a New Treatment Option for Non-malignant Disorders: Radiobiological Mechanisms, Clinical Applications, and Radiation Risk. Page:74—84
30. The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus. Page:65—73
31. Risk Factors of Osteoporosis in Rheumatoid Arthritis Patients; Glucocorticoid, Inactivity, or Nutrient Deficiencies. Page:63—64
32. A Case of Paget's Disease Involving Pelvic Bone in a Patient with Tophaceous Gouty Arthritis. Page:60—61
33. Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Diagnosis and Assessment of Takayasu Arteritis and Ulcerative Colitis. Page:55—59
34. Four Cases of Polyarteritis Nodosa Presenting Initially as Pain and Pitting Edema in Both Lower Extremities. Page:48—54
35. Refractory Pleural Effusion in Systemic Lupus Erythematosus Treated by Pleurectomy. Page:43—47
36. Nutrient Intake in Postmenopausal Rheumatoid Arthritis Women with Osteoporosis: Results from the Korean National Health and Nutrition Examination Survey. Page:35—42
37. Cost-effectiveness of Non-steroidal Anti-inflammatory Drugs Adjusting for Upper and Lower Gastrointestinal Toxicities in Rheumatoid Arthritis Patients. Page:27—34
38. Manifestations of Cervical Spine Involvement in Longstanding Ankylosing Spondylitis: Atlantoaxial Ankylosis and Atlantoaxial Subluxation. Page:21—26
39. Interleukin-32 Gamma as a New Face in Inflammatory Bone Diseases. Page:14—20
40. Nuclear Medicine Imaging in Rheumatic Diseases. Page:4—13
41. Homo-Genius: Homocitrulline Can Be a Better Target than Citrulline as a Biomarker for Rheumatoid Arthritis?. Page:1—3
42. Recurrent Aseptic Meningitis in Kikuchi-Fujimoto Disease: A Not So Benign Disease?. Page:318—320
43. Pancreatic Neuroendocrine Tumor Presenting with Arthritis and Panniculitis. Page:313—317
44. Acquired Hemophilia A Combined with Systemic Lupus Erythematosus: A Case Report and Literature Review. Page:309—312
45. Focal Eosinophilic Myositis Associated with Behçet's Disease. Page:303—308
46. Cardiovascular and Gastrointestinal Effects of Etoricoxib in the Treatment of Osteoarthritis: A Systematic Review and Network Meta-analysis. Page:293—302
47. Comparison of the Disease Activity Score-28 Based on the Erythrocyte Sedimentation Rate and C-reactive Protein in Rheumatoid Arthritis. Page:287—292
48. Association of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Mean Platelet Volume with Systemic Lupus Erythematosus Disease Activity: A Meta-analysis. Page:279—286
49. Interleukin-17 Enhances Germinal Center Formation and Immunoglobulin G1 Production in Mice. Page:271—278
50. Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy. Page:261—270
51. The Role of Bile Acid Receptors in Chronic Inflammatory Diseases. Page:253—260
52. Association between Treatment with Biologic Agents and the Incidence of Herpes Zoster in Rheumatoid Arthritis. Page:251—252
53. Progressive Occipitocervical Subluxation Despite Biologic Agent Therapy in a Patient with Advanced Rheumatoid Arthritis. Page:169—170
54. Hypereosinophilic Syndrome Associated with the Onset of Rheumatoid Arthritis: A Case Report. Page:165—168
55. A Case of Neutrophilic Myositis. Page:161—164